RELEASE: ICP DAS - BMP will show high-performance medical TPU granules to the visitors of KIMES 2023

(Information sent by the signatory company).

RELEASE: ICP DAS - BMP will show high-performance medical TPU granules to the visitors of KIMES 2023

(Information sent by the signatory company)

- ICP DAS - BMP will show high-performance medical TPU granules to KIMES 2023 visitors in Seoul, Korea

HSINCHU, March 8, 2023 /PRNewswire/ -- ICP DAS - BMP (Biomedical Polymers), a Taiwanese supplier of medical TPU (Thermoplastic Polyurethane), will have its first showcase at KIMES 2023, Korea. Among the products exhibited, the TPU granules with radiopacifiers of 50% tungsten (W50) and 40% barium sulfate (B40), respectively, stand out. The Doctor

ICP DAS - BMP will exhibit three series of highly stable medical grade TPU granules, namely Alithane™ (ALP series), Durathane™ (ALC series) and Arothane™ (ARP series). All TPU pellets are 100% made in Taiwan and have passed the USP Class VI test and/or ISO 10993 biocompatibility test.

To differentiate from the compounding process, ICP DAS - BMP developed a unique one-step polymerization process to produce TPU granules containing color masterbatch and radiopaque fillers to elevate the performance properties of our materials for various medical applications, including catheters. medical devices, cancer treatment devices and metal guide liners.

We also carry out extensive quality inspections of each batch produced to ensure batch-to-batch consistency of our medical TPU granules, meeting customer requirements, i.e. mechanical and physical properties and processability.

An expert team, rigorous testing, superior properties, shortest delivery times - all of these have earned us the trust of manufacturers around the world. We expect our TPU sales in China, India, Europe and the United States to increase this year, and we are poised to excel in this field on a global scale.

Come and meet our professionals in hall D, booth DL130, from March 23 to 26 at the COEX fairgrounds.

About ICP DAS - BMP

Amid the growing global demand for TPU from the medical industry, ICP DAS established a new business unit ICP DAS - BMP in 2018 to develop and produce medical grade TPU. We have obtained ISO 13485 manufacturing certification for our TPU to ensure product safety and quality.

ICP DAS - BMP has its own laboratories for polymerization, physical and chemical property analysis, mechanical testing, and cytotoxicity testing. In addition, the TPUs we manufacture are USP Class VI and ISO 10993 certified: ISO 10993-4 for hemocompatibility tests, ISO 10993-5 for cytotoxicity tests, ISO 10993-10 for skin irritation and sensitization tests, ISO 10993- 11 for systemic toxicity tests and ISO 10993-23 for irritation tests. Our product series are also REACH and RoHS compliant.

For more details visit our website: https://bmp.icpdas.com/

Photo - https://mma.prnewswire.com/media/2017313...Logo - https://mma.prnewswire.com/media/1934616...

View original content: https://www.prnewswire.com/news-releases/icp-das---bmp-mostrara-a-los-visitantes-de-kimes-2023-los-granulos-de-tpu-medico-de-alto-rendimiento-301764737.html

NEXT NEWS